Abstract
THE central aminergic neurones present some original characteristics. By means of quantitative autoradiographic studies, it has been demonstrated that serotoninergic terminals projecting into the cerebral cortex and the locus coeruleus exhibit very few classical synaptic contacts1,2. This has also been seen with cortical noradrenergic terminals1. It has been suggested that the amines could be released not only in synapses, but also from varicosities devoid of synaptic junctions: they could thus act as neuromodulators at some distance from the release sites. It has also been proposed that dopamine could be released from dendrites of nigrostriatal dopaminergic neurones3. Indeed, a release of endogenous dopamine (Cuello, personal communication) or of labelled dopamine4,5 previously taken up in tissues, has been demonstrated using slices of the rat substantia nigra exposed to a high concentration of potassium (30 mM). This process was calcium dependent. An indication of possible dendritic release was also obtained indirectly in vivo by measuring dopamine metabolites in the rat substantia nigra6. Dihydroxyphenylacetic acid and homovanillic acid levels were increased after stimulation of the medial forebrain bundle, which contains axons of various ascending aminergic pathways including the nigrostriatal dopaminergic system. Therefore, dopamine could be released not only from nerve terminals in the striatum, but also from dendrites in the substantia nigra. If the latter mechanism was occuring in physiological states, it could have important implications for the understanding of the regulatory processes involved in the control of the activity of the dopaminergic neurones. It thus seemed necessary to demonstrate directly an in vivo release of dopamine in the substantia nigra.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Descarries, L., Beaudet, A. & Watkins, K. C. Brain Res. 100, 563–588 (1975).
Descarries, L. & Leger, L. International Symposium on Interactions among Putative Neurotransmitters in the Brain (eds Garattini, S., Pujol, J. F. & Samanin, R.) (Raven, New York, in the press).
Björklund, A. & Lindvall, O. Brain Res. 83, 531–537 (1975).
Cuello, A. C. & Iversen, L. L. International Symposium on Interactions among Putative Neurotransmitters in the Brain (eds Garattini, S., Pujol, J. F. & Samanin, R.) (Raven, NewYork, in the press).
Geffen, L. B., Jessell, T. M., Cuello, A. C. & Iversen, L. L. Nature 260, 258–260 (1976).
Korf, J., Zieleman, M. & Westerink, B. H. C. Nature 260, 257–258 (1976).
Chéramy, A., Nieoullon, A. & Glowinski, J. Naunyn Schmiedeberg Archiv. Pharmac. (in the press).
Nieoullon, A., Chéramy, A. & Glowinski, J. J. Neurochem. (in the press).
Besson, M. J., Chéramy, A., Feltz, P. & Glowinski, J. Brain Res. 32, 407–424 (1971).
Chéramy, A., Gauchy, C., Glowinski, J. & Besson, M. J. Eur. J. Pharmac. 21, 246–248 (1973).
Descarries, L. & Droz, B. C.r. Acad. Sci., Paris, 266, 2480–2482 (1968).
Sotelo, C. J. Ultrastruct. Res. 36, 824–841 (1971).
Pickel, V. M., Joh, T. H., Field, P. M., Becker, C. G. & Reis, D. J. J. Histochem. Cytochem. 23, 1–12 (1975).
Aghajanian, G. K. & Bunney, B. S. Frontiers in Catecholamine Research (eds Usdin, E. & Snyder, S.) 643–648 (Pergamon, New York, 1973).
Chéramy, A., Nieoullon, A. & Glowinski, J. International Symposium on Interactions among Putative Neurotransmitters in the Brain (eds Garattini, S., Pujol, J. F. & Samanin, R.) (Raven, New York, in the press).
Hajdu, F., Hassler, R. & Bak, I. J. Z. Zellforsch. 146, 207–221 (1973).
Groves, P. M., Wilson, C. J. & McGregor, R. J. International Symposium on Interactions among Putative Neurotransmitters in the Brain (eds Garattini, S., Pujol, J. F. & Samanin, R.) (Raven, New York, in the press).
Kebabian, J. W. & Saavedra, J. M. Science 193, 683–684 (1976).
Phillipson, O. T. & Horn, A. S. Nature 261, 418–420 (1976).
Prémont, J. et al. FEBS Lett 68, 99–104 (1976).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
NIEOULLON, A., CHERAMY, A. & GLOWINSKI, J. Release of dopamine in vivo from cat substantia nigra. Nature 266, 375–377 (1977). https://doi.org/10.1038/266375a0
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1038/266375a0
This article is cited by
-
α-Synuclein-induced dysregulation of neuronal activity contributes to murine dopamine neuron vulnerability
npj Parkinson's Disease (2021)
-
Clock controls circadian period in isolated suprachiasmatic nucleus neurons
Nature Neuroscience (1998)
-
Direct monitoring of dopamine and 5-HT release in substantia nigra and ventral tegmental area in vitro
Experimental Brain Research (1994)
-
Dopaminergic neurotransmission in somatodendritic and terminal areas of the rat brain: susceptibility to modulation by D 1 and D2 receptors and to axotomy
Journal of Neural Transmission (1992)


